Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data

por Lee, Chung-Shien, Milone, Matthew, Seetharamu, Nagashree
Publicado 2021

The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges

por Oduah, Eziafa I., Lee, Chung-Shien, Seetharamu, Nagarashee
Publicado 2022

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives

por Fraser, Madison, Seetharamu, Nagashree, Diamond, Matthew, Lee, Chung-Shien
Publicado 2023

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer

por Wang, Kevin Y, Newman, James, Lee, Chung-Shien, Seetharamu, Nagashree
Publicado 2021

Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer

por Lee, Chung-Shien, Devoe, Craig E, Zhu, Xinhua, Fishbein, Joanna Stein, Seetharamu, Nagashree
Publicado 2020

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity

por Lee, Chung-Shien, Sharma, Sandhya, Miao, Emily, Mensah, Cheryl, Sullivan, Kevin, Seetharamu, Nagashree
Publicado 2020

A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer

por Lee, Chung-Shien, Lam, So Yi, Liu, Angel, Sison, Cristina, Zhu, Xin-Hua
Publicado 2023